AstraZeneca_NNP Annual_JJ Report_NNP and_CC Financial_NNP Statements_NNP Form_NN 20-F_NNP Information_NNP 2003_CD 111_CD 35_CD Called-up_JJ share_NN capital_NN of_IN parent_NN company_NN Allotted_NNP ,_, called-up_JJ Authorised_NNP and_CC fully_RB paid_VBN 2003 2003 2002_CD $_$ m_CD $_$ m_CD $_$ m_CD Ordinary_NNP Shares_NNP $_$ 0.25_CD each_DT 423 423 429_CD Unissued_NNP Ordinary_NNP Shares_NNP $_$ 0.25_CD each_DT 177_CD Redeemable_JJ Preference_NNP Shares_NNP 1_CD each_DT 50,000_CD 600 423 429_CD The_DT Redeemable_JJ Preference_NN Shares_NNS carry_VBP limited_JJ class_NN voting_NN rights_NNS and_CC no_DT dividend_NN rights_NNS ._.
This_DT class_NN of_IN shares_NNS is_VBZ capable_JJ of_IN redemption_NN at_IN par_NN at_IN the_DT option_NN of_IN the_DT Company_NN on_IN the_DT giving_VBG of_IN seven_CD days_NNS written_VBN notice_NN to_TO the_DT registered_VBN holder_NN of_IN the_DT shares_NNS ._.
The_DT movements_NNS in_IN share_NN capital_NN during_IN the_DT year_NN can_MD be_VB summarised_VBN as_IN follows_VBZ :_: No._NN ._.
of_IN shares_NNS million_CD $_$ m_CD At_IN beginning_NN of_IN year_NN 1,719_CD 429_CD Issues_NNS of_IN shares_NNS 11_CD Re-purchase_NN of_IN shares_NNS 27_CD 7_CD At_IN 31_CD December_NNP 2003_CD 1,693_CD 423_CD Share_NN buy-back_NN During_IN the_DT year_NN the_DT Company_NN purchased_VBD ,_, and_CC subsequently_RB canceled_VBN ,_, 27,211,500_CD Ordinary_NNP Shares_NNP at_IN an_DT average_JJ price_NN of_IN 2535_CD pence_NN per_IN share_NN for_IN a_DT consideration_NN ,_, including_VBG expenses_NNS ,_, of_IN $_$ 1,154_CD m._FW The_DT excess_NN of_IN the_DT consideration_NN over_IN the_DT nominal_JJ value_NN has_VBZ been_VBN charged_VBN against_IN the_DT profit_NN and_CC loss_NN account_NN reserve_NN ._.
Share_NN schemes_NNS A_DT total_NN of_IN 1,240,117_CD Ordinary_NNP Shares_NNP were_VBD issued_VBN during_IN the_DT year_NN in_IN respect_NN of_IN share_NN schemes_NNS ._.
Details_NNS of_IN movements_NNS in_IN the_DT number_NN of_IN Ordinary_NNP Shares_NNP under_IN option_NN are_VBP shown_VBN in_IN Note_NN 30_CD :_: details_NNS of_IN options_NNS granted_VBN to_TO Directors_NNS are_VBP shown_VBN in_IN the_DT Directors_NNS Remuneration_NNP Report_NNP ._.
